A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Sanofi's $1.6B acquisition and a groundbreaking…
EMA’s CHMP issued an opinion not to recommend Elevidys™ (delandistrogene moxeparvovec) for the treatment of ambulatory individuals with Duchenne muscular…
Spanning 11 studies across the U.S., Canada, Sweden, and Australia, the newly funded research explores interventions for young people dealing…
Harnessing Voice Analysis, NuCalm's Breakthrough Technology Determines Your Stress Level with Ease and Accuracy LOS ANGELES, July 23, 2025 /PRNewswire/…
BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) and Inmagene Biopharmaceuticals (“Inmagene”)…
BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) and Inmagene Biopharmaceuticals (“Inmagene”)…
Transforming a promising molecule into a clinically viable therapeutic platform Jupiter, Florida, July 23, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences,…
WATERTOWN, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics…
MIDDLETON, Wis., July 22, 2025 /PRNewswire/ -- Natus Medical Incorporated is continuing its commitment to innovation and expanding the functionality of…
NEW ORLEANS, July 22, 2025 /PRNewswire/ -- Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative…